Ozicef T 250mg/31.25mg Injection
Marketer
Skyways Healthcare Pvt Ltd
Salt Composition
Ceftriaxone (250mg) + Tazobactum (31.25mg)
Overview Ozicef T 250mg/31.25mg Injection
Cefixime and Sulbactam injection (250mg/31.25mg), sold as Ozicef T, combats bacterial infections by inhibiting microbial growth and spread. Administer this combination drug only as directed by a healthcare provider. Complete the prescribed course, even with symptom improvement; premature cessation may reduce efficacy. Potential side effects include nausea, vomiting, diarrhea, and indigestion. Report worsening side effects or allergic reactions (rash, itching, swelling, breathing difficulty) immediately. Inform your doctor of all current medications, and pregnant or breastfeeding individuals should seek medical advice before use. Avoid alcohol due to potential increased drowsiness. While generally not impairing driving ability, refrain from driving if experiencing drowsiness or dizziness. Rest, a balanced diet, and adequate hydration promote recovery. Your physician may order tests to monitor the medication's effects.
Uses of Ozicef T 250mg/31.25mg Injection
Infections caused by bacteria
Major Benefits of Ozicef T 250mg/31.25mg Injection:
Administering this medication will be handled by your healthcare provider. Self-medication is strictly prohibited.
Common Side effects of Ozicef T 250mg/31.25mg Injection:
- Diarrhea
- Increased liver enzymes
- Allergic reaction
- Rash
How to use Ozicef T 250mg/31.25mg Injection:
This medication will be administered by your healthcare provider. Self-medication is strongly discouraged.
How Ozicef T 250mg/31.25mg Injection works:
The injectable drug Ozicef T, containing 250mg Ceftriaxone and 31.25mg Tazobactum, utilizes a dual-action mechanism. Ceftriaxone, a third-generation cephalosporin antibiotic, disrupts bacterial cell wall synthesis, inhibiting bacterial growth. Tazobactum, a beta-lactamase inhibitor, counteracts bacterial resistance mechanisms, thereby boosting Ceftriaxone's effectiveness.
SAFETY ADVICE
AlcoholSAFE
There are no known adverse reactions associated with the concurrent use of Ozicef T 250mg/31.25mg Injection and alcohol.
PregnancySAFE IF PRESCRIBED
Pregnancy use of Ozicef T 250mg/31.25mg Injection is generally deemed safe. Preclinical trials in animals revealed minimal or absent harm to offspring; clinical data from human trials, however, remain scarce.
Breast feedingCAUTION
Administering Ozicef T 250mg/31.25mg Injection to breastfeeding mothers requires careful consideration. Mothers should discontinue breastfeeding throughout the course of treatment and until the medication is fully cleared from their system.
DrivingUNSAFE
The administration of Ozicef T 250mg/31.25mg Injection can induce drowsiness, visual disturbances, and dizziness. Refrain from operating a vehicle should these effects manifest.
KidneyCONSULT YOUR DOCTOR
Insufficient data exists regarding the administration of Ozicef T 250mg/31.25mg Injection to individuals with renal impairment. Seek medical advice.
LiverCAUTION
The injectable medication, Ozicef T 250mg/31.25mg, requires careful administration in individuals with significant hepatic impairment; dosage modification may be necessary. Consult a physician for guidance. Dosage alteration for Ozicef T 250mg/31.25mg Injection is not advised for those with mild or moderately compromised liver function.
What if you forget to take Ozicef T 250mg/31.25mg Injection :
Omit a dose of Ozicef T 250mg/31.25mg Injection? Seek your physician's advice.
Facts to Know About Ozicef T 250mg/31.25mg Injection
| Label | Value |
|---|---|
| Developing Habits | No. |
| Type of Treatment | Antimicrobial Agents |
3,018 People bought this recently